Top Markets
Coin of the day
WayPoint Biomedical Holdings, Inc. WayPoint Biomedical Holdings, Inc.

WayPoint Biomedical Holdings, Inc.

WYPH
Rang in aandelen #41550
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary,... WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Aandeelprijs
$0.0005
Laatst gesynchroniseerd: 2026-08-12
Marktkapitalisatie
$16.62K
Verandering (1 dag)
-64.29%
Verandering (1 jaar)
400.00%
Land
US
Handel WayPoint Biomedical Holdings, Inc. (WYPH)

Categorie

Dividendrendementgeschiedenis voor WayPoint Biomedical Holdings, Inc. (WYPH)
Het dividendrendement (TTM) van WayPoint Biomedical Holdings, Inc. (aandelsymbool: WYPH) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van WayPoint Biomedical Holdings, Inc. (WYPH) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
0.88%
US
0.00%
CA
0.00%
US
3.30%
AU
0.82%
US